Stock ALMEX MEXEDIA S.P.A.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Mexedia S.p.A.

Equities

ALMEX

IT0005450819

Market Closed - Euronext Paris
Other stock markets
 03:00:29 2024-06-25 EDT 		5-day change 1st Jan Change
8.75 EUR +0.57% Intraday chart for Mexedia S.p.A. -4.37% -41.67%
04-09 Futures down; major order for Fincantieri AN
04-08 Indices up; Interpump tops on Mib. AN

Summary

  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The stock, which is currently worth 2024 to 0.29 times its sales, is clearly overvalued in comparison with peers.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

  • As estimated by analysts, this group is among those businesses with the lowest growth prospects.
  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company has insufficient levels of profitability.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

Ratings chart - Surperformance

Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality
-
  1. Stock Market
  2. Equities
  3. ALMEX Stock
  4. Ratings Mexedia S.p.A.